enGene Holdings Eyes Oncology: Gene-Delivery Platform Could Pivot to Cancer Therapy
enGene Holdings is evaluating an oncology pivot by adapting its targeted gene-delivery technology for cancer drugs. Early-stage data, strategic alliances, and regulatory steps will shape prospects.
Seeking Alpha
2 min read
Stocks
Biotechnology
Healthcare